Related Experiment Video
Updated: Aug 15, 2026

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
Liposome-encapsulated antibiotics
Isam I Salem1, Diana L Flasher, Nejat Düzgüneş
1Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, Spain.
Abstract:
Encapsulation of certain antibiotics in liposomes can enhance their effect against microorganisms invading cultured cells and in animal models. We describe the incorporation of amikacin, streptomycin, ciprofloxacin, sparfloxacin, and clarithromycin in a variety of liposomes. We delineate the methods used for the evaluation of their efficacy against Mycobacterium avium-intracellulare complex (MAC) infections in macrophages and in the beige mouse model of MAC disease. We also describe the efficacy of pH-sensitive liposomes incorporating sparfloxacin or azithromycin. We summarize studies with other antibiotics, including rifampicin, rifabutin, ethambutol, isoniazid, clofazimine, and enrofloxacin, and their use against MAC, as well as other infection models, including Mycobacterium tuberculosis.
Insights
Liposome encapsulation enhances antibiotic efficacy against Mycobacterium avium-intracellulare complex (MAC) infections in cells and animal models. This study evaluates various liposomal antibiotics, including sparfloxacin and azithromycin, for improved MAC treatment.
Area of Science:
- Pharmacology and Drug Delivery
- Microbiology and Infectious Diseases
- Biotechnology and Nanomedicine
Background:
- Liposome encapsulation is a promising strategy to improve antibiotic delivery and efficacy.
- Mycobacterium avium-intracellulare complex (MAC) infections pose significant challenges, particularly in immunocompromised individuals.
- Current treatments for MAC infections often face limitations in efficacy and require prolonged therapy.
Purpose of the Study:
- To evaluate the efficacy of various antibiotics encapsulated in liposomes against MAC infections.
- To investigate the potential of pH-sensitive liposomes for enhanced drug delivery in MAC disease models.
- To explore liposomal formulations of antibiotics for treating MAC and other mycobacterial infections.
Main Methods:
- Incorporation of antibiotics (amikacin, streptomycin, ciprofloxacin, sparfloxacin, clarithromycin) into diverse liposomal formulations.
- In vitro evaluation of liposomal antibiotic efficacy against MAC in macrophage cell cultures.
- In vivo assessment using the beige mouse model of MAC disease and studies with Mycobacterium tuberculosis models.
Main Results:
- Liposomal encapsulation demonstrated enhanced efficacy of tested antibiotics against MAC infections.
- pH-sensitive liposomes incorporating sparfloxacin or azithromycin showed promising results in MAC models.
- Studies with other antibiotics (rifampicin, isoniazid, etc.) in liposomal form were summarized, indicating broad applicability.
Conclusions:
- Liposome-encapsulated antibiotics represent a viable strategy to improve treatment outcomes for MAC infections.
- The development of targeted liposomal drug delivery systems offers a promising avenue for combating mycobacterial diseases.
- Further research into liposomal antibiotic formulations could lead to more effective therapies for challenging infections.
Related Concept Videos
Lysosomes
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Formation of Lipopolysaccharides
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis

